REDWOOD CITY, Calif. (AP) _ Guardant Health Inc. (GH) on Thursday reported a loss of $54.6 million in its second quarter.

The Redwood City, California-based company said it had a loss of 57 cents per share.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.

The provider of oncology testing services posted revenue of $66.3 million in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $59.8 million.

Guardant Health shares have increased almost 6% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $82.75, a decrease of almost 9% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH

Automated Insights, source Associated Press News